Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre‐eclampsia
- 1 May 1993
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 100 (5) , 416-420
- https://doi.org/10.1111/j.1471-0528.1993.tb15264.x
Abstract
To establish the plasma evolution of prothrombin fragments 1+2 (F 1+2), thrombin-antithrombin III complexes (TAT), fibrin fragment D-Dimers (DD), von Willebrand factor antigen (vWf), Type 1 plasminogen activator inhibitor antigen (PAI) and blood platelet count during normal pregnancy and to compare these values with those obtained in hypertensive or pre-eclamptic pregnancies. Cross-sectional study. Forty-seven healthy pregnant women with gestational age ranging between 5 and 40 weeks, and fourteen women with gestational age ranging between 25 and 38 weeks presenting with either gestational hypertension (n = 4) or pre-eclampsia (n = 10). Numbers of nulliparous women in the control, hypertension and pre-eclampsia groups were 13/47 (28%), 1/4 (25%) and 9/10 (90%), respectively. All six markers increased with gestational age in normal pregnant women (P < 0.01). Using the upper limit of 95% prediction interval obtained from regression curves as normality threshold, TAT showed the best sensitivity (71% vs < 30% for F1+2, DD, vWf, PAI and platelet count). TAT appears to be an interesting marker for detecting haemostatic system alterations in pregnancies complicated by hypertension or pre-eclampsia. A large prospective study to determine its clinical usefulness for such complicated pregnancies is currently in progress.Keywords
This publication has 18 references indexed in Scilit:
- Prothrombin fragment 1 + 2, thrombin–antithrombin III complexes and D‐dimers in acute deep vein thrombosis: effects of heparin treatmentBritish Journal of Haematology, 1991
- Thrombin‐antithrombin III complex levels in normal pregnancy with hypertensive disorders and after deliveryBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Enhanced thrombin generation in normal and hypertensive pregnancyAmerican Journal of Obstetrics and Gynecology, 1989
- Clinical Significance, Prevalence, and Natural History of Thrombocytopenia in Pregnancy-Induced HypertensionAmerican Journal of Perinatology, 1989
- Placental-type plasminogen activator inhibitor in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1988
- 264 Plasma levels of fibronectin, plasminogen activator inhibitor 1 and fibrin fragment d-dimer in preeclampsiaFibrinolysis, 1988
- Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.Journal of Clinical Investigation, 1985
- FACTOR VIII COMPLEX IN NORMAL PREGNANCY, PRE‐ECLAMPSIA AND FETAL GROWTH RETARDATIONBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- Studies on Blood Coagulation and Fibrinolysis in Pregnancy, during Delivery and in the PuerperiumGynecologic and Obstetric Investigation, 1981
- FACTOR-VIII COMPLEX FETAL GROWTH RETARDATION, AND TOXÆMIAThe Lancet, 1977